John Marcolini Sells 553 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) SVP John Marcolini sold 553 shares of the business’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $53,370.03. Following the sale, the senior vice president owned 13,843 shares of the company’s stock, valued at approximately $1,335,987.93. This represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Itron Trading Up 0.2%

Shares of ITRI stock traded up $0.21 during mid-day trading on Tuesday, reaching $96.98. The company’s stock had a trading volume of 1,110,135 shares, compared to its average volume of 687,927. The company’s 50 day simple moving average is $118.11 and its 200-day simple moving average is $122.55. Itron, Inc. has a 12-month low of $90.11 and a 12-month high of $142.00. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $4.44 billion, a PE ratio of 16.58, a price-to-earnings-growth ratio of 0.76 and a beta of 1.52.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share for the quarter, topping analysts’ consensus estimates of $1.48 by $0.06. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm had revenue of $581.63 million during the quarter, compared to analysts’ expectations of $578.49 million. During the same period in the prior year, the company earned $1.84 EPS. The firm’s revenue was down 5.5% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.840-6.940 EPS. Q4 2025 guidance at 2.150-2.250 EPS. On average, research analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Institutional Trading of Itron

Several institutional investors and hedge funds have recently bought and sold shares of the company. Royce & Associates LP bought a new stake in shares of Itron in the 1st quarter valued at approximately $448,000. Pinnacle Wealth Management Advisory Group LLC boosted its holdings in Itron by 7.3% in the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company’s stock worth $246,000 after purchasing an additional 160 shares during the period. GSA Capital Partners LLP increased its stake in Itron by 32.9% during the first quarter. GSA Capital Partners LLP now owns 5,725 shares of the scientific and technical instruments company’s stock valued at $600,000 after purchasing an additional 1,416 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Itron during the first quarter worth $1,212,000. Finally, Bayforest Capital Ltd lifted its position in shares of Itron by 43.9% in the 1st quarter. Bayforest Capital Ltd now owns 3,980 shares of the scientific and technical instruments company’s stock worth $417,000 after buying an additional 1,215 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. increased their target price on Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Thursday, October 16th. Argus reaffirmed a “hold” rating on shares of Itron in a research report on Tuesday, November 4th. Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a research report on Saturday, November 1st. Baird R W downgraded shares of Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. Finally, Johnson Rice downgraded shares of Itron from a “buy” rating to an “accumulate” rating in a research note on Friday, August 1st. Nine research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Itron currently has a consensus rating of “Moderate Buy” and an average price target of $139.00.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.